MSB 2.03% $1.45 mesoblast limited

2023 The Final Countdown, page-1920

  1. 2,480 Posts.
    lightbulb Created with Sketch. 274
    I hate the rampers on this forum, but speaking independently - the gvhd treatment is already approved in Japan. that's no small feat. their standards are high.

    the previous fda submission response wasn't a rejection, it was a "revise and resubmit".

    msb have revised and have now resubmitted.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.